Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RDS - BG purchase worked out pretty well.
NKE - complaint reminds me of the alleged evil messages coming from Beatles vinyl rotated in reverse direction. Or perhaps this is just the start of the cyber warfare for the 2020 election cycle.
https://www.businessinsider.com/nike-air-max-270-criticized-by-muslims-arabic-script-2019-1
Very little from me personally. It will be the emerging upper middle class in EM economies that can afford better holidays to farther places.
BA IMO travel via flights should continue to benefit from low fuel costs for the foreseeable future with less frequent supply shocks.
GME - I've been following the company for a several years now mainly as a reason of complaints by game playing teenagers that used to shop there. These kids are all grown ups now and still gaming but none go to physical stores for content. For sale sign has been put out by management for at least the last 3 years with no interest shown previously. The last WSJ piece repeated company's for sale sign with no analysis IMO just to generate a short squeeze for some hedge fund(s). No analysis was offered. DJ other reporter covering GME at MarketWatch had the situation nailed in December.
discl. I am short Feb 12 naked calls for a few weeks now and hedge them yesterday with otm puts. This thing will eventually go the way of blockbuster, sharper image and radio shack.
GME - For a little money, you too can push an agenda with WSJ "journalists". Then the truth comes later.
http://news.gamestop.com/news-releases/news-release-details/gamestop-concludes-process-pursue-sale-company
It is questionable whether big cities (34 cities cited) can be considered "emerging" any longer. If rural areas were included, then I would agree with the "emerging" descriptor.
China Daily article suggest PFE will expand PFP model to other markets beyond China.
http://global.chinadaily.com.cn/a/201901/24/WS5c491f38a3106c65c34e642c.html
AAPL self-driving dissolving. Lack of car/partner, lousy Map and zero data makes it hard to compete. I was extremely impressed by Tesla's latest AP version. Took a self driving ride in an X and it made it most of the way from school in town to hotel in the next town, through many lights and trafficky areas, 12 miles each way.
https://www.bloomberg.com/opinion/articles/2019-01-24/apple-autonomous-car-project-titan-dismissals-show-challenges
Hydrogen - reform from CH4. Compression and cryo delivery to "stations". That was the dream to extend legacy oil company business models post ICE. The idea is around 2 decades old at least and TM and GM (via BLDP) were also in that crystal ball. There is just no way this can compete with solar PV generation now below 0.03/kwh not including storage, utility scale or distributed.
TM - finally making a serious move towards EVs. Perhaps a real step in abandoning the Japex/CVX/RDS/XOM decades old dream of H2 infrastructure. What a colossal waste of money it turned out to be.
https://www.bloomberg.com/opinion/articles/2019-01-22/toyota-panasonic-battery-venture-is-an-electric-car-power-shift
Augmedics - private.
"Revanesse " ?
Anything to do with rvnc?
COMEDIAN SAM !
Daimler - EV trucks for port of Long Beach/Los Angeles. The I-710 corridor between the port and train depot near downtown LA has to be one of the biggest smog generator in the LA Basin. This is an easy target given the relatively short distance between the port and the depot.
https://chargedevs.com/newswire/daimler-delivers-first-freightliner-electric-commercial-truck-to-penske/
BA - Wanted BETA testers 50 mile range currently.
https://www.bloomberg.com/news/articles/2019-01-23/boeing-s-flying-car-takes-off-to-show-a-glimpse-of-the-future?srnd=hyperdrive
correction - Verb CEO left year end with no comment. Still looking for replacement.
Gasoline in NYC is that cheap? No wonder the roads there are so crappy. A fill up for 330i in CA would cost $50-60 depending on where you live. Around $55 at my closest gas stations.
JNJ - frigiting about their future in med robotics. ISRG already has a lung biopsy robot with tech licensed from the same company mentioned below. CEO at Verb (JV between goog and jnj) was recently replaced.
https://www.bloomberg.com/news/articles/2019-01-23/j-j-is-said-to-pursue-deal-for-robotic-surgery-firm-auris-health
PS. trxc advanced energy device got FDA clearance recently making their tool set more and more like isrg's.
https://www.medtechdive.com/news/fda-clears-energy-tools-for-transenterix-robotic-surgery-system/546161/
EDIT/NTLA/CRSP all taking hits. Bubble bursting?
Go for a used Leaf unless you need the space to lug around stuff or need to drive commute distances on regular basis. I need the space for outdoorsy things that I do and it is just a lot more convenient to throw stuff into the hatch than to get roof rack and tie downs.
For those optimistic about oil prices. All about EOR in tight stuff.
https://s1.q4cdn.com/594864049/files/doc_presentations/2018/12/December-Corporate-Presentation_FINAL.pdf
Capex on renewables dropped last year mainly due to China restricting feed in solar subsidies. Still GW capacity went up significantly because PV module prices went down faster than the drop in Capex.
https://about.bnef.com/blog/clean-energy-investment-exceeded-300-billion-2018/
YOY they are still up quite a bit still. They cut 10% in Q1 of last year (no. of employees went up for the year +17% if recollection serves) and production went up so I expect the same and launch of attack at lower price points or upgrade in driving range, or both. ie higher range for S and X and lower price point for 3.
EYPT/OCUL - eypt moved up their launch date for post cataract surgery anti-inflammatory behind the iris insert (placed as part of cataract procedure) to Q1 from Q2. Ocul has a less invasive insert that goes into the tear duct area (cleared in December and has not announced launch timing). Both are sustain-release steroids that last 30 days. Any thoughts or comments on market share? Current SOC is 30 days of eye drops.
NASH focused stocks seem to be affected by Bloomberg article about the curse of big pharma blockbusters. mdgl vktx galt glmd icpt etc..
https://www.bloomberg.com/news/articles/2019-01-11/big-pharma-faces-the-curse-of-the-billion-dollar-blockbuster?srnd=businessweek-v2
ThunderHorse memories - One of the previews of the final act at MaCondo.
http://www.dieselduck.info/images/thunderhorse/index.htm
PS. The 1 Billion headline is deceptive. They knew they had that much to begin with. It just moved from the P3 column to P2/P1.
"As low as $100" per metric ton. That's impressive if achievable (equivalent to $5/mcf) if a field doesn't have easy access to piped CO2 for EOR purposes. OXY is apparently interested from that angle.
Jeffries and others are all angling to get pieces of lyft and uber IPOs probably has some influence on valuationalizing. The last market valuation I have was $15B for mobileye 30 months ago.
TRXC - +14% on preliminary earnings corporate update PR. 3 systems to EU, 1 to Asia and 1 to US. Decent disposables revs. Still wanted to see more US systems sales.
http://ir.transenterix.com/news-releases/news-release-details/transenterix-provides-corporate-update-1
GME - more of the same rumor and WSJ decides to push the buyout story as the stock slides down the slope of hope. Murdoch has NOT been good for the quality of reporting at WSJ. Short via a few call options today.
Re WSJ journal article on shale well long term decline rates. I no longer subscribe and have not read the article. I have in the past found that their coverage of in the weeds issues in the oil patch to be lacking. They are good at corporate level reporting, special assignments like the BP blowout and analysis. I doubt the reporter in this case has any insights based upon my review of what has been reported by companies and SPE (see link below). I don't know if the reporter's comments take into account the IP and flush production period (the first several months to 2 years) or if he is referring to the long term decline as discussed in the SPE review. From a well profitability perspective, IP and flush production is much more important than when the wells enter into long term decline. Also, the analysis is being done on older frac tech wells >5 yrs old. Even then, it is a second order effect on economics given the time discount.
One item that caught my attention was PXD slide that suggest that oil recovery factor can be significantly boosted via EOR. I assume the analog would be North Cross (see link at bottom), and oil is still being stripped there after many years of injection. If PXD and OXY (took over north cross from Shell) can find even a fraction of the NCross success with the process, there would be a big ramp up in production from old plays if prices are sufficiently high.
https://www.spe.org/en/jpt/jpt-article-detail/?art=4532
https://www.onepetro.org/conference-paper/SPE-170653-MS
AAPL -
Huawei flagship phone in China a lot less than AAPL's. Tariffs must level the playing field here.
https://www.bloomberg.com/news/articles/2019-01-03/apple-priced-itself-out-of-shrinking-chinese-smartphone-market?srnd=premium
Baloney in the longer term but I am sure there will be a short term dip in sales for Q1 as people accelerated purchases into 2018 to get the full tax credit. If you are in the mid luxury price range and need a new car, you still go the EV route and won't want to be stuck with an ICE car that will be obsoleted within a decade. Unless you are driving a company or business car in which case depreciation is not a concern.
Was shopping for unlocked Pixel 3 or XL version last week and found it disappointing that all the brands are chasing iPhone price point for equivalent reviewer ratings. Even Huawei flagship is priced the same (which is probably taking iPhone market share in greater China given recent DOJ action). I refrained. Will just wait and be perfectly happy with version negative 1.0 as long as the battery last and camera is decent.
https://www.psychologytoday.com/us/blog/rewired-the-psychology-technology/201606/are-we-all-becoming-pavlov-s-dogs
Some stuff I reviewed in gathering thoughts regarding WSJ comments about tight production at big independents. I will post comments later.
1. psd dec 2018 pdf investor presentation
2. pxd BofA webcast presentation
3. eog q3 presentation
4. nee svp development presentation to academics 2017
http://investors.pxd.com/static-files/63fce5a6-0808-4982-b332-f58685745f92
https://www.veracast.com/webcasts/baml/energy2018/id31210231897.cfm?0.0816697342049
http://investors.eogresources.com/Cache/1001245049.PDF?O=PDF&T=&Y=&D=&FID=1001245049&iid=4075407
Thx. Will do.
IYO what's CARA's theoretical edge over currently available anti-itch choice(s) for renal associated itching?
HAIR - heavy tax loss selling rebound I thought. But there is also this sale in Europe PRIOR to CE Mark. I guess the buyer is confident of approval or in a country with no personal injury lawsuit risks. I am pretty sure that they will get CE Marking. It is usually the other way around in that medical device companies get CE Mark first, gather data then apply for FDA clearance.
https://globenewswire.com/news-release/2019/01/02/1679530/0/en/Restoration-Robotics-Secures-ISO-13485-2016-Certification.html
I have always thought that HF via HCM or DCM is a lot more idiopathic and complex than some simple mechanical explanation like "hyper" contractility.